Jane Hsiao

Dr. Jane H.
Hsiao is a Chairman & Chief Executive Officer at Non-Invasive Monitoring Systems, Inc. and a Co-Vice Chairman & Chief Technical Officer at OPKO Health, Inc. She is on the Board of Directors at OPKO Health, Inc., Fabrus, Inc. and Froptix Corp.
Dr. Hsiao was previously employed as an Independent Director by Cocrystal Pharma, Inc., an Independent Director by Sorrento Therapeutics, Inc., an Independent Director by Neovasc, Inc., an Independent Director by OPKO Biologics Ltd., a Vice Chairman & Chief Technical Officer by eXegenics, Inc., a Chairman by Cellular Technical Services Co., Inc., an Independent Director by Asensus Surgical, Inc., a Chairman, President & Chief Executive Officer by IVAX Animal Health, Inc., a Chairman, President & Chief Executive Officer by DVM Pharmaceuticals, Inc., a Vice Chairman-Technical Affairs by IVAX Corp., a President & Director by Aero Pharmaceuticals, Inc., a Vice President by Baker Norton Pharmaceuticals, a General Partner by HSU Gamma Investments LP, a President by Innotech Laboratories, Inc., and a Vice President by The Frost Group LLC.
She also served on the board at BioZone Pharmaceuticals, Inc., Cocrystal Discovery, Inc., Orthodontix, Inc., SafeStitch Medical, Inc., Ivax Pharmaceuticals sro, IVAX Diagnostics, Inc., Acuity Pharmaceuticals, Inc., Great Eastern Bank of Florida, IVAX Dermatologicals, Inc., Kunming Baker Norton Pharmaceutical Co. Ltd., Medical Ventures Corp., Protalix Biotherapeutics, Inc. and TransEnterix, Inc. /Old/.
She received her undergraduate degree from National Taiwan University, an MBA from Nova Southeastern University, Inc. and a doctorate degree from the University of Illinois.